（记者 王瀚黎） 每经AI快讯，信达证券1月27日晚间发布公告称，公司限售股份约25.51亿股将于2026年2月2日解禁并上 市流通，占公司总股本比例为78.67%。 每经头条（nbdtoutiao）——国际金价冲破5000美元！7年涨了280%，什么时候才见顶？专家：关键还 看美元，重点关注国际货币体系、降息和科技革命 ...

证券代码：601059 证券简称：信达证券 公告编号：2026-002 信达证券股份有限公司 首次公开发行部分限售股份上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股票上市类型为 首发 股份；股票认购方式为 网下 ，上市股数为 2,551,400,000股。 本次股票上市流通总数为2,551,400,000股。其中首发限售股上市流通数量为 2,551,400,000 股，首发战略配售股上市流通数量为 0 股。 本次股票上市流通日期为2026 年 2 月 2 日。 一、本次限售股上市类型 经中国证券监督管理委员会于 2022 年 12 月 12 日出具的《关于核准信达证券 股份有限公司首次公开发行股票的批复》（证监许可〔2022〕3121 号）核准，信 达证券股份有限公司（以下简称公司或信达证券）向社会公开发行人民币普通股 （A 股）股票 324,300,000 股，并于 2023 年 2 月 1 日在上海证券交易所主板上市 交易。 本次上市流通的限售股数量为 2,551,400,000 ...

中信建投证券股份有限公司 关于信达证券股份有限公司 首次公开发行股票部分限售股份上市流通的核查意见 中信建投证券股份有限公司（以下简称"保荐机构"）作为信达证券股份有 限公司（以下简称"信达证券"或"公司"）首次公开发行股票并上市之保荐机 构，根据《中华人民共和国公司法》《中华人民共和国证券法》《证券发行上市保 荐业务管理办法》《上海证券交易所股票上市规则》《上海证券交易所上市公司自 律监管指引第 11 号——持续督导》等相关法律法规和规范性文件的要求，对信 达证券首次公开发行股票部分限售股份上市流通的情况进行了核查，具体情况如 下： 一、本次限售股上市类型 经中国证券监督管理委员会《关于核准信达证券股份有限公司首次公开发行 股票的批复》（证监许可〔2022〕3121 号）核准，公司首次公开发行 324,300,000 股社会公众股于 2023 年 2 月 1 日起在上海证券交易所主板上市交易。信达证券 首次公开发行股票前总股本为 2,918,700,000 股，发行后总股本为 3,243,000,000 股。 本次申请上市流通的限售股为公司首次公开发行限售股，锁定期为自公司股 票上市之日起 36 个月，本次 ...

人民财讯1月27日电，信达证券（601059）发布公告称，股东中国信达持有的25.51亿股限售股份将于 2026年2月2日起上市流通。该部分股份为首发限售股，占公司当前总股本的78.67%。本次上市流通 后，该公司首次公开发行限售股已全部解禁。 ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 智通财经记者 | 陈靖 2026年开年未满一月，证券行业遭遇监管部门的密集整治与精准问责。 据智通财经统计，截至目前，监管层已累计下发罚单14张，波及11家券商，分别为万和证券、浙商证券 （601878.SH）、华林证券（002945.SZ）、渤海证券、华泰证券（601688.SH）、华金证券、信达证券 （601059.SH）、国新证券、江海证券、金圆统一证券等，9名相关责任人被依法追责问责。 处罚问题包括IPO保荐失职、两融业务违规、持续督导缺位、从业人员违规炒股等核心业务环节的乱 象，清晰释放出监管层坚守合规底线、从严整治行业生态的强烈信号。 1月23日，辽宁证监局、浙江证监局同步公示两张罚单，直指券商内控缺陷与高管履职失责两大痛点。 其中，华林证券辽宁分公司因在投诉事项处置过程中，存在不相容岗位未有效分离的违规情形，被监管 部门出具警示函。 依据《证券经纪业务管理办法》第四十条规定，证券公司必须遵循独立制衡原则设定岗位、梳理业务流 程，确保营销、合规风控、账户办理等岗位严格分设，重要业务岗位实行双人复核制度。华林证券此次 违规触碰 ...

近期，信达澳亚基金的最新公告显示，公司已完成第七届董事会换届选举。根据股东会决议，唐伦飞、 李泉、方敬和刘兴华将担任公司第七届董事会董事。同时，陈建瑜、陈蓉和谭劲松被任命为第七届董事 会独立董事，而宋若冰、杨棉之和屈文洲则不再担任独立董事职务 新一届董事会核心团队亮相 唐伦飞作为新当选的董事长，拥有丰富的金融机构管理经验。他曾在信达证券股份有限公司和中国信达 资产管理股份有限公司投融资业务部任职。其职业生涯还包括担任中国信达（香港）控股有限公司风险 总监、党委委员以及中国信达资产管理股份有限公司业务审核部副总经理等职务。从2025年12月25日 起，他已经担任信达澳亚基金董事长。 | 唐伦飞 | 男 年龄:48岁 国籍:中国 籍贺: | 信达费亚基金管理有限公司 | | --- | --- | --- | | 兰特时代 | 信达证券股份有限公司 | | | 108 | 工作电话:一 | | | 邮箱: -- | 联系地址: -- | | | 人物介绍 | | | | 曾任职于信达证券股份有限公司，中国信运资产管理股份有限公司股融资业务部:历任中国信达(香港波股有限公司风险 | A 115 MACC 22 C ...

Core Viewpoint - The non-bank financial sector has experienced significant fluctuations, with the insurance sector reaching a five-year high before facing a two-week correction, highlighting a divergence in the driving logic between insurance and brokerage firms [1] Group 1: Insurance Sector Value Reassessment - The insurance sector is undergoing a value reassessment driven by liability-side reforms, asset-side recovery, and regulatory easing, leading to sustained fundamental improvements since 2025 [2] - Structural optimization on the liability side is central to the value recovery, with regulatory changes lowering the guaranteed interest rates for various insurance products, thus alleviating long-term risks and improving the cost structure [3] - The asset side has seen a reversal in returns, with the ten-year government bond yield stabilizing at 1.84% by the end of 2025, improving the industry's profit outlook and driving significant profit growth among major insurers [4] - Regulatory easing and product strategy optimization have created a synergistic effect, supporting valuation recovery in the insurance sector, particularly through the promotion of dividend insurance products [5] Group 2: Liquidity Support in the Insurance Sector - The influx of medium- to long-term funds into the market has become a key feature since 2025, with these funds favoring high-dividend assets, making the insurance sector a primary beneficiary [6] - Policies initiated in early 2025 aimed at promoting medium- to long-term funds entering the market have provided comprehensive institutional support for insurance investments [6] - A positive cycle has formed where increased returns from equity investments lead to more funds flowing into the insurance sector, enhancing liquidity and market activity [7] Group 3: Brokerage Sector Performance and Future Direction - The brokerage sector is experiencing a paradox of high earnings growth but stagnant stock prices, attributed to regulatory changes and shifts in market funding flows [8] - Despite impressive earnings growth in 2025, the brokerage sector has not led market rallies, contrasting sharply with its role during the 2015 bull market, due to intensified regulation and a shift in investor focus [9] - Mergers and acquisitions are seen as a necessary path for restructuring the brokerage industry, with government support aimed at enhancing international competitiveness and optimizing resource allocation [12] Group 4: Structural Opportunities in Non-Bank Financial Sector - The non-bank financial sector is positioned for structural opportunities as the equity market recovers, benefiting from increased trading volumes and improved profitability in both brokerage and insurance sectors [13] - The brokerage sector is currently undervalued, with significant potential for valuation recovery, particularly through mergers and acquisitions that enhance competitive positioning [14] - The insurance sector is expected to see continued growth in new policy premiums, driven by attractive product offerings in a low-interest-rate environment, making it a core focus for investment [15]

Group 1: Commercial Aerospace - China's recent successful launch of low-orbit satellites and the application for over 203,000 satellite frequency resources to the International Telecommunication Union (ITU) indicates intensified competition in the commercial aerospace sector [2] - The launch of 19 low-orbit satellites by the Long March 12 rocket marks a significant achievement, highlighting the strategic importance of satellite frequency resource competition [2] Group 2: Humanoid Robotics - The humanoid robotics industry is accelerating towards mass production, with Tesla planning to sell its Optimus robot to the public by the end of 2027 and YuTree projecting over 5,500 units of humanoid robots to be shipped by 2025 [3] - Domestic leading companies in the humanoid robotics sector are advancing their capitalization processes, with several firms completing share reforms and expediting their listing processes [3] Group 3: Industrial Technology Companies - Dayun Technology, a leading supplier of industrial X-ray intelligent detection equipment, reported a nearly 100% year-on-year increase in new orders in the first half of 2025, with a revenue growth of 44.01% and a net profit growth of 18.83% in the first three quarters [4] - Kangst, engaged in the development and sales of digital testing instruments, experienced a significant upward trend in Q3 2025, with revenue, net profit, and net profit excluding non-recurring items increasing by 22.24%, 30.66%, and 36.2% respectively [5] - Newray Co., which specializes in hard alloy products, reported a revenue growth of 38.02% and a net profit growth of 75.40% in Q3 2025, driven by effective cost transmission amidst rising raw material prices [6]

Core Viewpoint - Under the backdrop of accelerating global trade friction, the company has maintained stable revenue through increased market share with existing clients and the acquisition of new clients, although profit growth is constrained by factors such as ramping up overseas production capacity and domestic brand investments [1] Group 1: Financial Performance - The company is expected to see a steady recovery in profitability in 2026, supported by the advantages of its production capacity in Thailand and the gradual maturity of overseas supply chains [1] - The trend of downstream production transfer is expected to continue, leading to a further concentration of supply share [1] Group 2: Strategic Developments - In 2025, the company plans to undergo a dual upgrade of its brand center organization and capabilities, establishing an independent team for research, production, and sales to achieve an end-to-end closed loop from market insight to product definition and shelf placement [1] - The company has set ambitious goals, aiming for brand revenue to approach manufacturing revenue by 2028, with expectations for high growth in its OBM (Original Brand Manufacturer) business [1] Group 3: Investment Rating - The company maintains a "Buy" rating based on its growth prospects and strategic initiatives [1]

Core Viewpoint - The report from Cinda Securities indicates that Bailong Chuangyuan is expected to achieve record high performance in both 2025 and Q4 2025, driven by further capacity release and continuous growth in sales [1] Industry Summary - The food and beverage market is anticipated to experience a peak in the launch of new products this year, particularly with the introduction of D-alloheptulose, following the adoption of allulose by brands like Nayuki's Tea and Mengniu's UHT probiotic drink [1] - There is a clear global trend towards healthier food options, which is expected to sustain the growth of multiple products offered by the company, while the penetration rate still has room for improvement, indicating potential future growth [1] Company Summary - The company is actively expanding its production capacity both domestically and internationally, which is aimed at supporting global sales and growth while reducing costs [1] - Earnings per share (EPS) projections for the company are set at 0.87, 1.11, and 1.45 yuan for the years 2025, 2026, and 2027 respectively, corresponding to price-to-earnings ratios (PE) of 28X, 22X, and 17X for those years [1] - The company maintains a "buy" rating based on its growth prospects and market positioning [1]